|
Volumn 17, Issue 3, 2009, Pages 164-166
|
[Bringing the antiviral therapy home for chronic hepatitis B patients: host immunity influences the efficacy and disease prognosis].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
IMMUNOLOGICAL ADJUVANT;
VIRUS DNA;
ARTICLE;
BLOOD;
DRUG EFFECT;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
PROGNOSIS;
VIROLOGY;
VIRUS REPLICATION;
ADJUVANTS, IMMUNOLOGIC;
ANTIVIRAL AGENTS;
DNA, VIRAL;
HEPATITIS B E ANTIGENS;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B VIRUS;
HEPATITIS B, CHRONIC;
HUMANS;
IMMUNOTHERAPY;
PROGNOSIS;
VIRUS REPLICATION;
|
EID: 70449714637
PISSN: 10073418
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|